Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes.
- Published In:
- Journal of translational medicine, 23(1), 546 (2025)
- Authors:
- Karuna, Narainrit, Tonry, Claire, Ledwidge, Mark, Glezeva, Nadezhda, Gallagher, Joe, McDonald, Ken, Watson, Chris J
- Database ID:
- RPEP-11736
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11736APA
Karuna, Narainrit; Tonry, Claire; Ledwidge, Mark; Glezeva, Nadezhda; Gallagher, Joe; McDonald, Ken; Watson, Chris J. (2025). Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes.. Journal of translational medicine, 23(1), 546. https://doi.org/10.1186/s12967-025-06563-7
MLA
Karuna, Narainrit, et al. "Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes.." Journal of translational medicine, 2025. https://doi.org/10.1186/s12967-025-06563-7
RethinkPeptides
RethinkPeptides Research Database. "Proteomic-based biomarker discovery reveals panels of diagno..." RPEP-11736. Retrieved from https://rethinkpeptides.com/research/karuna-2025-proteomicbased-biomarker-discovery-reveals
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.